Oncotelic Therapeutics, Inc.·4

May 2, 5:00 PM ET

Trieu Vuong 4

4 · Oncotelic Therapeutics, Inc. · Filed May 2, 2023

Insider Transaction Report

Form 4
Period: 2023-05-02
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2023-05-02$0.04/sh+100,000$4,50090,917,329 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    6,872,529
  • Common Stock

    (indirect: By Autotelic, Inc.)
    16,780,384

Documents

1 file
  • 4
    ownership.xmlPrimary